Search, Find and Buy Antibodies, ELISA Kits and Proteins.
Loading Loading
Order hotline:
phone +1 404 474 4654
fax +1 888 205 9894 (TF)
Details for Product No. ABIN628968

Q-VD-OPh

Request
Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Application
Functional Studies (Func), Cell Culture (CC)
Pubmed 6 references available
Catalog no. ABIN628968
Quantity 3 mg
Price
478.50 $   Plus shipping costs $45.00
Shipping to
Availability Will be delivered in 2 to 3 Business Days
Sequence Quinolyl-Val-Asp-OPh
Characteristics A synthetic peptide that is potent, cell permeable, nontoxic and irreversibly inhibits caspase activity to blocks apoptosis. The new generation of caspase inhibitor is more stable in aqueous environment and exhibits several folds higher activity than the corresponding FMK caspase inhibitors. Q-VD-OPH is the inhibitor of choice for both in vitro and in vivo studies.
Purity > 95 % by HPLC
Molecular Weight 513.49 Da
Research Area Kinases/Phosphatases
Restrictions For Research Use only
Format Lyophilized
Handling Advice Protect from light and moisture.
Storage -20 °C
Expiry Date 12 months
Product cited in: Höglund, Nilsson, Forshell et al.: "Myc sensitizes p53-deficient cancer cells to the DNA-damaging effects of the DNA methyltransferase inhibitor decitabine." in: Blood, Vol. 113, Issue 18, pp. 4281-8, 2009 (PubMed).

Yamanouchi, Morgan, Kato et al.: "Effects of caspase inhibitor on angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice." in: Arteriosclerosis, thrombosis, and vascular biology, Vol. 30, Issue 4, pp. 702-7, 2010 (PubMed).

Rana, Gupta, Gomez et al.: "Securinine induces p73-dependent apoptosis preferentially in p53-deficient colon cancer cells." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 24, Issue 6, pp. 2126-34, 2010 (PubMed).

Novgorodov, Chudakova, Wheeler et al.: "Developmentally regulated ceramide synthase 6 increases mitochondrial Ca2+ loading capacity and promotes apoptosis." in: The Journal of biological chemistry, Vol. 286, Issue 6, pp. 4644-58, 2011 (PubMed).

Höglund, Nilsson, Muralidharan et al.: "Therapeutic implications for the induced levels of Chk1 in Myc-expressing cancer cells." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 17, Issue 22, pp. 7067-79, 2011 (PubMed).

Frisan, Vandekerckhove, de Thonel et al.: "Defective nuclear localization of Hsp70 is associated with dyserythropoiesis and GATA-1 cleavage in myelodysplastic syndromes." in: Blood, Vol. 119, Issue 6, pp. 1532-42, 2012 (PubMed).

Beacon